Originally form Ireland, Owen moved Belgium in 2018 to join ULiège on a Marie Curie Postdoctoral Fellowship. In 2021 he obtained a permanent position in the university as a Research Logistician for the new Aqua-Platform and in 2023 he joined the board of the Belgian Society for Virology
Owen's expertise lies primarily in the field of virology, (specifically herpesviruses), RNA-interference mechanisms, molecular biology and bioinformatics. Since joining ULiège in 2018, he has engaged in research into, RNA-based innate immune stimulation to aid vaccine design, viral and host transcriptomics, and host immune response pathway network analysis, use of neural netwroks to understand complex datasets, viral genome assembly, viral evolutionary analysis, nature conservation, and fundamental virology.
After graduation from Dublin City University (DCU) in 2008 (BSc. in Genetics and Cell Biology), he joined the Marine Institute, Galway where he gained over 4 years experience in infectious disease surveillance and also did a PhD. After this he joined University of Galway working on the development of point of care diagnostic device In 2014, he joined Elanco (part of the Eli Lilly Group), a vaccine biotech company in then based in Sligo. In 2017, he joined the Technological university of the Shannon (TUS), as Post-Doctoral Research Officer where he managed a diverse scientific platforms, before joining the University of Liege in 2018 on a Marie Curie Fellowship.
Originally form Ireland, Owen moved Belgium in 2018 to join ULiège on a Marie Curie Postdoctoral Fellowship. In 2021 he obtained a permanent position in the university as a Research Logistician for the new Aqua-Platform and in 2023 he joined the board of the Belgian Society for Virology
Owen's expertise lies primarily in the field of virology, (specifically herpesviruses), RNA-interference mechanisms, molecular biology and bioinformatics. Since joining ULiège in 2018, he has engaged in research into, RNA-based innate immune stimulation to aid vaccine design, viral and host transcriptomics, and host immune response pathway network analysis, use of neural netwroks to understand complex datasets, viral genome assembly, viral evolutionary analysis, nature conservation, and fundamental virology.
After graduation from Dublin City University (DCU) in 2008 (BSc. in Genetics and Cell Biology), he joined the Marine Institute, Galway where he gained over 4 years experience in infectious disease surveillance and also did a PhD. After this he joined University of Galway working on the development of point of care diagnostic device In 2014, he joined Elanco (part of the Eli Lilly Group), a vaccine biotech company in then based in Sligo. In 2017, he joined the Technological university of the Shannon (TUS), as Post-Doctoral Research Officer where he managed a diverse scientific platforms, before joining the University of Liege in 2018 on a Marie Curie Fellowship.